INTRA-ARTERIAL INFUSION of acetylcholine (ACh) or cholinergic agonists increases cerebral blood flow and this increase is blocked by atropine.
1 " 3 Histological studies revealed a rich innervation of cholinesterase-stained neurons in cerebral arteries of humans, 4 monkeys 5 and other species. 6 7 Since development of a sensitive radioenzymatic assay for endogenous choline acetyltransferase (ChAT) activity, 8 ' 9 high ChAT activity was detected in cerebral arteries of rabbits, 10 " cats 10 ' " and dogs." The existence of 3 H-QNB binding sites, muscarinic cholinergic receptor sites was noted on the postsynaptic receptor sites of cholinergic innervation in the bovine 1213 and rat cerebral arteries. 14 These findings suggest that cholinergic innervation reaches intraparenchymal vessels. 1314 Significant species differences were noted in the response of cerebral blood vessels to ACh. In isolated cat cerebral arteries, various concentrations of ACh produced dual responses; low concentrations of ACh (<1 x 10~4M) induced relaxation, and high concentrations of ACh (>1 X 10" 4 M) induced contraction." Isolated dog cerebral arteries contracted in the presence of a low concentration of ACh (1 X 10~7M), under certain experimental conditions. 16 On the other hand, various concentrations of ACh induced only re-length). Ligatures were placed on both ends of the strips and one end was attached to a tissue holder and the other to a strain gauge force-displacement transducer (Nihonkoden, Tokyo, Japan) connected to a polygraph (San-ei Instrument, Tokyo, Japan) on which isometric tension changes were recorded. Each strip was then placed in a 20 ml tissue organ bath containing physiological salt solution of the following composition (mM) NaCl 120; KC1 4.7; MgSO 4 1.2; KH 2 PO 4 1.2; CaCl 2 2.5; NaHCO 3 25 and glucose 10. The solution was maintained at 37 ± 0.5°C and bubbled with 95% O 2 and 5% CO 2 (pH 7.4) throughout the experiments. An initial 1.5 g tension was applied to each strip and an equilibration period of 120 min was allowed before commencement of experiments.
Binding Assay
The arteries were minced with scissors and homogenized in 10 volumes of ice-cold 50 mM sodium phosphate buffer (pH 7.4) with a glass homogenizer. The homogenates were filtered through two layers of gauze, re-homogenized at a setting of 10 on a Polytron homogenizer with 20 s burst, the homogenates centrifuged at 1,000 x g for 10 min and the supernatant carefully removed and centrifuged at 100,000 x g for 60 min. The resulting pellet was resuspended in 50 mM sodium phosphate buffer (pH 7.4). Protein concentration was determined by the method of Lowry et al. 17 3 H-QNB bindings were performed by incubating aliquots of the cerebral artery homogenates at a temperature 37°C for 60 min in 250 /xl of sodium phosphate buffer, containing 3 H-QNB in the absence or presence of high concentrations of atropine (1 fxM). The binding in the presence of 1 /AM atropine was termed "nonspecific" and was subtracted from that obtained in the absence of 1 fiM atropine "total binding", to obtain the binding termed "specific binding". The assay was terminated by addition of 3 ml of the ice-cold buffer and rapid filtration through Whatman GF/B glass fiber filters under suction. After washing twice with 3 ml of the buffer, the filters were dried in an oven, transferred to counting vials and 8 ml of scintillation fluid added. Radioactivity was counted in a Packard Tri-Carb scintillation spectrometer (Model 3255).
Scatchard analysis was performed according to Bennet. 18 ChAT Assay
ChAT activity in the 1000 x g supernatant fraction of the human cerebral arteries was measured according to the procedure of Fonnum 8 9 as modified by Florence and Bevan." Incubation was carried out for 12 minutes at 37° C.
Chemicals and Reagents 3 H-QNB (36 Ci/mmol) and l4 C-acetyl-coenzyme A (58 mCi/mmol) were obtained from New England Nuclear, Boston, Mass., and cold QNB was a gift from Dr. S. Spector, Roche Institute of Molecular Biology, Nutley, N.J. All other chemicals were of reagent grade and were obtained commercially.
Statistical Evaluations
The results given in the text are means ± S.E. of N experiments. The regression lines were calculated by a non-linear least square method using a computer program. The K, values for displacement of 3 H-QNB binding by cholinergic agents were determined from concentration-response curves.
Results

Responses to Exogenous ACh
Responses to exogenously applied ACh were examined in isolated helical preparations of human and dog cerebral arteries. In human cerebral arteries, ACh induced relaxations, in a dose dependent manner (figs. 1,2). Contractions were not observed in any preparation tested (N = 12). The EC^ of ACh was 6.1 ± 0.2 x 10" 6 M. These relaxations were blocked by atropine (1 x 10' 7 M). In dog cerebral arteries, ACh first induced relaxation when the concentration was lower than 1 x 10" 7 M and a higher concentration of ACh (1 x 10" 5 M) led to contraction (figs. 1, 2). The EC^ of ACh required to induce relaxation was 7.2 ± 0.2 x 
FIGURE 2. Dilatory effect of ACh on isolated human and dog cerebral arteries. Twelve human cerebral arteries (6 middle cerebral, 4 posterior cerebral, I anterior cerebral, I basilar) were tested. Points represent the means ± S.E. for 12 experiments in human cerebral arteries (o); and 5 experiments in dog cerebral arteries (•). EC so s were 6.1 ± 0.2 x 10~6M in human cerebral arteries (N = 12) and 7.2 ± 0.2 X 10~7M in dog cerebral arteries (N = 5), respectively.
10
T M (N = 5). Both relaxation and contraction were blocked by atropine (1 x 1 0 "^) . binding but only in high concentrations in case of human cerebral arteries. The Ki values of nicotine and cytisine were 3.5 ± 1.8 x 10" 3 M and 5.7 ± 4.1 x 10-5 M, respectively.
H-QNB Binding
ChAT Activity in Cerebral Arteries
ChAT activities in the human and dog cerebral arteries were 1.6 ± 0.4 nmol/mg protein/hr in the former (N = 6) and 3.7 ± 0 . 1 nmol/mg protein/hr in the latter (N = 6).
Effects of Postmortem Delay in Freezing Tissue After Death on ^-QNB Binding and ChAT Activity Dog cerebral arteries were studied under two conditions: (A) tissue frozen immediately after death and stored, and (B) tissue frozen 2hr after death and stored. 3 H-QNB binding at the concentration 0.45 nM was 137 + 10 fmol/mg protein (N = 4) at the condition (A) and 128 ± 6 fmol/mg protein (N = 4) at the condition (B), respectively. ChAT activity was 3.7 ± 0.1 nmol/mg protein/hr (N = 6) at the condition (A) and 3.6 ± 0.2 nmol/mg protein/hr (N = 4) at the condition (B), respectively. The effects of 2 hrs postmortem delay in freezing the tissue on 3 H-QNB binding and ChAT activity were not significant. 20 dog portal vein 21 and bovine pial arteries. 12 ChAT, the synthesizing enzyme of ACh, is useful marker of cholinergic innervation of presynaptic sites. 8 - 9 As we detected ChAT activity in both human and dog cerebral arteries, these arteries seem to possess functional cholinergic innervation. ChAT activity of 3.7 ± 0.1 nmol/mg protein/hr in dog cerebral arteries is similar to the value given in the literature." In cerebral arteries, levels of ChAT activity appear to correlate with high affinity choline uptake and evoked ACh release. 10 ' " ChAT activity in human cerebral arteries was about half as high as that in dog cerebral arteries. Delay in freezing the tissue obtained at autopsy may have some effect on the ChAT activity in human cerebral arteries, however, the effect is probably not significant, since the ChAT activity was confirmed to be stable within 2 hrs in dog cerebral arteries and it is stable up to 72 hrs in the mouse brain. 22 Lower ChAT activity in human cerebral arteries suggests that the density of cholinergic innervation may be lower than that in dog cerebral arteries. 12 Ki values for other cholinergic agents were also larger than values in case of dog cerebral arteries. 3 H-Nmethylscopolamine binding to rat brain were gradually decreased within 24 hrs after death. 24 We obtained human cerebral arteries within 2 hrs of death and confirmed in dogs that such a delay does not have a significant effect on 3 H-QNB binding. Thus, the difference in 3 H-QNB bindings between human and dog cerebral arteries is probably due to species differences rather than to postmortem effects on the receptors. Pharmacodynamic studies revealed that human cerebral arteries react to vasoactive agents or neural stimuli in a manner different from that of cerebral arteries from other species. These species differences were given attention mainly with regard to adrenergic receptors. 2526 Regarding cholinergic innervation of human cerebral arteries, Edvinsson et al reported that unlike cat cerebral arteries, contractile responses were not obtained with various concentration of ACh, and that the concentration of ACh required to produce relaxation in human cerebral arteries was about 10 times as large as that in cat cerebral arteries. 4 -" In the present study, we also found that ACh induced only relaxation in the human cerebral arterial preparations and that the EC,,, of ACh was about 10 times higher, as compared with that of dog cerebral arteries. One possible explanation for this low responsiveness is the low affinity and density of muscarinic cholinergic receptors, in the human cerebral arteries. It was reported that ACh and ChAT activities in middle cerebral and basilar arteries in cats and dogs exist heterogenously. 10 ' " Muscarinic cholinergic receptors may also exist heterogenously at the arteries of anterior and posterior circulations. Further studies are underway to clarify regional differences in the receptors.
H-TABLE 1 Hill Coefficients and Ki Values for Cholinergic Agonists and Antagonists of 3 H-QNB Binding to Human and Dog Cerebral Arteries
In the present study on the isolated dog cerebral artery, ACh induced dual responses and in other studies, repetitive administration of ACh (1 x 10~7M)led to contraction. 16 On the other hand, ACh induced only relaxation in the human cerebral artery. Such a difference in the mechanical responses induced by ACh between dog and human cerebral arteries cannot be explained by differences in biochemical parameters of muscarinic receptors. Some populations of the muscarinic cholinergic receptors in the arteries were considered to locate on the vascular endothelium, as the relaxation to ACh disappeared after removal of the endothelium. 27 Estrada and Krause 12 reported that muscarinic cholinergic receptors have two classes of binding sites for agonists, in bovine cerebral arteries, and suggested that the binding site with a higher affinity for agonists on the endothelium mediates relaxation and that the other binding site with a lower affinity mediates contraction. The finding that higher concentrations of ACh induced contraction rather than relaxation in dog cerebral arteries seems to support this hypothesis. In human cerebral arteries, however, muscarinic cholinergic receptors also have two classes of binding sites for agonists, and only relaxation was produced by the administration of ACh. Further studies should clarify the physiological meaning of multiple binding sites for agonists and single binding sites for antagonists. The data Indicate that in vitro glucagon has a direct and substrate-specific stimulatory effect on isolated brain mitochondria. These substrate-specific effects were not altered when respiration was studied in the presence of postmitochondrial supernatant or exogenous 3',5'-cyclic AMP, indicating that glucagon, in addition to an in vivo action via activation of membrane-bound adenylate cyclase, can act, at least in vitro, directly and selectively on brain mitochondria. The results also support the postulate that glucagon's substrate-specific stimulation of mitochondrial oxidative phosphorylation, although not by direct enhancement of ketone oxidation, may play a role in cerebral protection against hypoxic damage in instances when circulating hormone levels are high.
Stroke Vol 17, No 2, 1986 PREVIOUS STUDIES from our laboratory demonstrated that, when mice were placed in an hypoxic environment, those with elevated blood ketones survived up to five times longer than controls.' Butanediol induced ketosis is also associated with a reduced neurologic deficit in the hypoxic rat. 2 Furthermore, this enhanced hypoxic tolerance in mice was potentiated by exogenous glucagon (GG). 3 In in vitro studies on rat brain slices we found that GG stimulates the incorporation of the ketone fceta-hydroxybutyrate (BHB) into carbon dioxide both in the presence or absence of added glucose. 4 In addition, Harris et al 5 have reported a stimulatory effect of GG on liver mitochondrial respiratory rates in the presence of BHB as a substrate. These results suggest an hypothesis that GG, in addition to its systemic effects, may increase hypoxic tolerance by modifying brain metabolism of ketones.
The ability of glucagon (GG) to alter cell metabolism is widely recognized,, but its mechanisms and sites of action remain to be fully elucidated. 6 For example, acute GG treatment of intact rats increases hepatic mitochondrial respiration and calcium fluxes.
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